These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 9519876

  • 1. The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS/WT1 oncoprotein are functionally distinct.
    Kim J, Lee K, Pelletier J.
    Oncogene; 1998 Feb 26; 16(8):1021-30. PubMed ID: 9519876
    [Abstract] [Full Text] [Related]

  • 2. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour.
    Lee SB, Kolquist KA, Nichols K, Englert C, Maheswaran S, Ladanyi M, Gerald WL, Haber DA.
    Nat Genet; 1997 Nov 26; 17(3):309-13. PubMed ID: 9354795
    [Abstract] [Full Text] [Related]

  • 3. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties.
    Kim J, Lee K, Pelletier J.
    Oncogene; 1998 Apr 16; 16(15):1973-9. PubMed ID: 9591781
    [Abstract] [Full Text] [Related]

  • 4. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator.
    Fujimura Y, Ohno T, Siddique H, Lee L, Rao VN, Reddy ES.
    Oncogene; 1996 Jan 04; 12(1):159-67. PubMed ID: 8552387
    [Abstract] [Full Text] [Related]

  • 5. EWS/Fli-1 chimeric protein is a transcriptional activator.
    Ohno T, Rao VN, Reddy ES.
    Cancer Res; 1993 Dec 15; 53(24):5859-63. PubMed ID: 7503813
    [Abstract] [Full Text] [Related]

  • 6. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
    Liu J, Nau MM, Yeh JC, Allegra CJ, Chu E, Wright JJ.
    Clin Cancer Res; 2000 Sep 15; 6(9):3522-9. PubMed ID: 10999739
    [Abstract] [Full Text] [Related]

  • 7. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains.
    Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ES.
    Oncogene; 1994 Oct 15; 9(10):3087-97. PubMed ID: 8084618
    [Abstract] [Full Text] [Related]

  • 8. The EWS-Oct-4 fusion gene encodes a transforming gene.
    Lee J, Kim JY, Kang IY, Kim HK, Han YM, Kim J.
    Biochem J; 2007 Sep 15; 406(3):519-26. PubMed ID: 17564582
    [Abstract] [Full Text] [Related]

  • 9. A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
    Werner H, Idelman G, Rubinstein M, Pattee P, Nagalla SR, Roberts CT.
    Cancer Lett; 2007 Mar 08; 247(1):84-90. PubMed ID: 16730884
    [Abstract] [Full Text] [Related]

  • 10. The Ewing's sarcoma gene product functions as a transcriptional activator.
    Rossow KL, Janknecht R.
    Cancer Res; 2001 Mar 15; 61(6):2690-5. PubMed ID: 11289149
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
    Fukuma M, Okita H, Hata J, Umezawa A.
    Oncogene; 2003 Jan 09; 22(1):1-9. PubMed ID: 12527902
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fusion of the EWS1 and WT1 genes as a result of the t(11;22)(p13;q12) translocation in desmoplastic small round cell tumors.
    Benjamin LE, Fredericks WJ, Barr FG, Rauscher FJ.
    Med Pediatr Oncol; 1996 Nov 09; 27(5):434-9. PubMed ID: 8827070
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
    Prasad DD, Ouchida M, Lee L, Rao VN, Reddy ES.
    Oncogene; 1994 Dec 09; 9(12):3717-29. PubMed ID: 7970732
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modification of EWS/WT1 functional properties by phosphorylation.
    Kim J, Lee JM, Branton PE, Pelletier J.
    Proc Natl Acad Sci U S A; 1999 Dec 07; 96(25):14300-5. PubMed ID: 10588700
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.